vimarsana.com

Page 7 - கனடா தொழில்துறை ஆராய்ச்சி உதவி ப்ரோக்ர்யாம் News Today : Breaking News, Live Updates & Top Stories | Vimarsana

COVID-19 vaccine maker Providence says it s leaving Canada after calls for more federal support go unanswered

COVID-19 vaccine maker Providence says it s leaving Canada after calls for more federal support go unanswered Manitoba buys made-in-Canada vaccine from Providence Therapeutics Replay Video UP NEXT © Providence Therapeutics/The Canadian Press A volunteer receives an injection in this undated handout image provided by Providence Therapeutics. The head of a homegrown company behind a promising COVID-19 vaccine says he s ready to pull his company out of Canada and take its product elsewhere after calls for more substantial federal support went unanswered. Brad Sorenson, the CEO of Calgary-based Providence Therapeutics, told CBC News he s had enough of the runaround from federal and provincial governments and he s working with the company s board of directors to move its operations overseas to focus on developing a vaccine for people in the southern hemisphere.

NA Proactive news snapshot: Weekend Unlimited Inc aka Potent Ventures Inc, CytoDyn Inc, PlantX Life Inc, PyroGenesis Canada Inc, Global Energy Metals Corporation, MagicMed Industries Inc,

NA Proactive news snapshot: Weekend Unlimited Inc aka Potent Ventures Inc, CytoDyn Inc, PlantX Life Inc, PyroGenesis Canada Inc, Global Energy Metals Corporation, MagicMed Industries Inc,
proactiveinvestors.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from proactiveinvestors.com Daily Mail and Mail on Sunday newspapers.

Q BioMed Updates Shareholders

Q BioMed Updates Shareholders Technology partner, Mannin Research, receives new R&D funding for COVID project and Several Milestones Expected in 2021 News provided by Share this article Share this article NEW YORK, April 27, 2021 /PRNewswire/ Q BioMed Inc. (OTCQB: QBIO), a commercial stage biotech company, updates shareholders. In March 2021,it was announced that our technology partner, Mannin Research Inc. (Mannin), is receiving up to CAD$1.7 million in research and development funding from the National Research Council of Canada Industrial Research Assistance Program (NRC IRAP) to support the pre-clinical development of a therapeutic to treat Acute Respiratory Distress Syndrome in COVID-19. This funding adds to approximately $7 million granted in Europe, which together will fund 65-75 percent of every dollar incurred to advance the Acute Respiratory Distress Syndrome therapy for COVID patients as well as a portfolio of therapeutic assets for vascular diseases currently i

Q BioMed Inc touts development progress of coronavirus treatment MAN-19 and other therapies in letter to shareholders

NA Proactive news snapshot: PlantX Life Inc, PyroGenesis Canada Inc, Global Energy Metals Corporation, MagicMed Industries Inc UPDATE …

A glance at some of the day s highlights from the Proactive Investors US and Canada newswires Your daily round-up from the world of Proactive Weekend Unlimited Inc (CSE:POT) (OTCQB:WKULF), a North American recreational cannabis and CBD wellness company, announced that it intends to change its name to Potent Ventures Inc. The Vancouver-based group also said that it plans to subdivide its common shares based on four new shares for every one existing common share. The company said that as part of the share split, registered shareholders of the company will receive four shares for each share held as of April 28, 2021. Weekend will continue to trade under its iconic CSE stock symbol POT.

© 2025 Vimarsana

vimarsana © 2020. All Rights Reserved.